Benzoylbenzimidazole-based selective inhibitors targeting Cryptosporidium parvum and Toxoplasma gondii calcium-dependent protein kinase-1.
Bioorg Med Chem Lett
; 22(16): 5264-7, 2012 Aug 15.
Article
em En
| MEDLINE
| ID: mdl-22795629
ABSTRACT
Calcium-dependent protein kinase-1 (CDPK1) from Cryptosporidium parvum (CpCDPK1) and Toxoplasma gondii (TgCDPK1) have become attractive targets for discovering selective inhibitors to combat infections caused by these protozoa. We used structure-based design to improve a series of benzoylbenzimidazole-based compounds in terms of solubility, selectivity, and potency against CpCDPK1 and TgCDPK1. The best inhibitors show inhibitory potencies below 50 nM and selectivity well above 200-fold over two human kinases with small gatekeeper residues.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Proteínas Quinases
/
Toxoplasma
/
Benzimidazóis
/
Proteínas de Protozoários
/
Cryptosporidium parvum
/
Inibidores de Proteínas Quinases
Idioma:
En
Ano de publicação:
2012
Tipo de documento:
Article